The key to pricing success for any pharmaceutical product is effectively exhibiting the asset’...
Read moreExecutive Summary What Has Changed in the Pharma Package? The Council’s agreed text on the Pha...
Read moreWhether you’re in drug development, market access, or health economics, early scientific advic...
Read moreCharlie Hewitt from Remap Consulting initiated today’s session by providing a description of the c...
Read moreAUTHORS: Amy Boyers, Solen Monteil, Mariam Bibi OBJECTIVES Early Access Programmes (EAPs) prov...
Read moreThe Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has implemented the Interna...
Read moreBack in January this year, we summarised the key trends our market access experts believed would dom...
Read moreWe're thrilled to announce our participation at ISPOR Europe 2023 in Copenhagen this November. We'll...
Read moreWe summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H...
Read moreOur market access experts provide an overview of how to get payer scientific advice between Septembe...
Read more